10,000 results
·
59ms
·
Sources: EU EUDAMED, US FDA
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACANALYSIS CDX
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx®
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·myChoice CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACANALYSIS CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·MyChoice® CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx®
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx
Tissue Adhesive For Internal Use
FDA Pre-Market Approval
FDA Class 3
·COHERA MEDICAL TISSUGLU SURGICAL ADHESIVE
Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees
FDA Pre-Market Approval
FDA Class 3
·OPRA Implant System
Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees
FDA Pre-Market Approval
FDA Class 3
·OPRA Implant System
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·MyChoice CDx®
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx®
Tissue Adhesive For Internal Use
FDA Pre-Market Approval
FDA Class 3
·COHERA MEDICAL TISSUGLU
Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees
FDA Pre-Market Approval
FDA Class 3
·OPRA Implant System
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·BRACAnalysis CDx®